期刊文献+

半乳糖化重组人生长激素的制备及其肝靶向性 被引量:3

Preparation of galactosyl recombinant human growth hormone and its hepatic targeting
下载PDF
导出
摘要 目的 :将重组人生长激素 (rhGH)进行半乳糖化修饰 ,制得半乳糖化重组人生长激素 (Gal rhGH) ,并研究其在小鼠体内的分布特征。方法 :以D 半乳糖为原料 ,制得双功能试剂 2 亚氨基 2 甲氧基乙基 1 硫代 β D 半乳吡喃糖苷 (IME) ,利用IME与重组人生长激素的碱性氨基酸偶合 ,制得Gal rhGH。以12 5I标记Gal rhGH和rhGH ,iv ,比较其在小鼠体内的组织分布。结果 :差热分析 (DTA)证实Gal rhGH是共价偶联物 ,平均糖密度为 5。iv后 ,12 5I rhGH Gal浓集于肝脏 ,最大分布量是12 5I rhGH的 2 .3倍 ;在肾脏 ,最大分布量仅为12 5I rhGH的 4 3 %。Gal rhGH在血、肝、肾、心、肺、脾、肠中全组织相对放射性分布的AUC分别是rhGH的 60 %,1 .5 5倍 ,5 8%,3 1 %,95 %,4 3 %,67%。结论 :成功地制备了化学偶联物Gal rhGH ,小鼠体内分布表明其具有明显的肝靶向性。 OBJECTIVE:To prepare galactosyl recombinant human growth hormone (Gal rhGH) and to study its distribution in mice.METHODS:A double function agent,2 imino 2 methoxyethyl 1 thio β D glycosides(IME) was prepared by D galactose through acetylation,bromination,condensation,displacement and addition reactions.Gal rhGH was prepared via IME attaching to the lysine residues on rhGH.RESULTS:Differential thermal analysis (DTA) verified that Gal rhGH was a covalent compound with mean 5 galactosyl residues per rhGH molecule.The comparative study of distribution in mice after iv showed that the radioactivity of 125 I rhGH Gal was concentrated in liver,whose maximum quantity was 2.3 times as that of 125 I rhGH.The distribution of 125 I rhGH Gal in kidney was 43% as that of 125 I rhGH.The AUC of whole tissue relative radioactivity distribution of 125 I rhGH Gal in blood,liver,kidney,heart,lung,spleen and intestine,were 60%,155%,58%,31%,95%,43%,67% as that of 125 I rhGH,respectively.CO NCLUSION:A hepatic targeting agent Gal rhGH was prepared successfully.
出处 《中国药学杂志》 CAS CSCD 北大核心 1999年第9期600-603,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金!第 3 96 70 86 1号
关键词 重组人生长激素 肝靶向性 Gal-rhGH 制备 药理 Recombinant human growth hormone,Galactosyl recombinant human growth hormone,hepatic targeting
  • 相关文献

参考文献4

二级参考文献8

  • 1管昌田,1990年
  • 2管昌田,中华核医学杂志,1990年,10卷,1期,81页
  • 3庞其捷,医药工业,1984年,3期,3页
  • 4Wu G Y,Biotherapy,1991年,3卷,87页
  • 5庞其捷,华西医科大学学报,1991年,22卷,368页
  • 6张其楷,药物设计原理,1990年
  • 7王葆仁,有机合成反应,1985年
  • 8朱俭,生物化学实验,1981年

共引文献21

同被引文献32

  • 1管昌田,梁正路,李云春,庞其捷,范举正,李铜铃.抗病毒药NGA-ACV的趋肝性及其机理研究[J].中华核医学杂志,1996,16(2):116-118. 被引量:9
  • 2张志荣.肝靶向米托蒽醌白蛋白微球的研究[J].药学学报,1997,32(1):72-78. 被引量:22
  • 3李云春,管昌田,杨晓川,李林,李静,李铜铃,庞其捷.半乳糖基人生长激素的肝靶向机理研究[J].中华核医学杂志,1997,17(2):106-108. 被引量:7
  • 4[4]Sxhlepper-schafer J, Hulsmann D, Djovlcar A, et al. Endocytosis via galactose receptor in vivo;ligand size directs uotake by hepatocytesand/or liver macrophages [J]. Exp Cell Res, 1986, 165:494.
  • 5[7]Driscoll CF. Magnetic targeting of microspheres in blood flow[J].Microvas Res, 1984, 27: 353-369.
  • 6Stowell CP,Lee YC.Neoglycoprotein the preparation and application of syntheticglycoproteins.Adv Carbohydr Chem Biochem,1980,37:350-281
  • 7Lee YTN.Distribution of adriamycin in cancer patients.Cancer,1980,45:2231-2239.
  • 8Didolkar MS.Comparison regional versus systemic chemotherapy with adriamyein.Ann Surg,1978,187:332-336.
  • 9Buchwald H.Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump.Cancer,1980,45:866-869.
  • 10Sxhlepper-schafer J,Hulsmann D,Djovlcar A,et al.Endocytosis via galactose receptor in vivo;ligand size directs uotake by hepatocytesand/or liver macrophages.Exp Cell Res,1986,165:494.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部